Raquel brings over 20 years of leadership experience in diagnostics, genomics and assay development, having most recently served as VP Science & Applications at Evonetix. There, she led multi-disciplinary teams across science and engineering, co-invented multiple patents, and played a key role in securing Series A and B funding. Earlier in her career at Solexa (later acquired by Illumina), Raquel helped establish the core molecular biology function and co-invented DNA polymerase technologies that were foundational to the company’s next-generation sequencing platform.
She has a PhD in Molecular and Cell Biology from Universite D’Auvergne, France and worked as a post doctoral researcher in the Department of Chemical Engineering and Biotechnology at the University of Cambridge. She also holds a MSc in Biochemistry from the University of Lisbon, Portugal.